| Name | RET-IN-8 |
|---|
| Description | RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H30N6O3 |
|---|---|
| Molecular Weight | 486.57 |